Latest & greatest articles for brimonidine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on brimonidine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on brimonidine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for brimonidine

21. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension

An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular (...) hypertension Stewart W C, Leech J, Sharpe E D, Kulze J, Ellyn J, Day D G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The authors investigated a switch to latanoprost monotherapy, or the addition of latanoprost or brimonidine

NHS Economic Evaluation Database.2002

22. Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model

Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model Abelson M B, Netland P A, Chapin M J Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of brimonidine monotherapy for the treatment of patients with glaucoma or ocular hypertension. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised adult patients with a history

NHS Economic Evaluation Database.2001

23. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma

Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma Einarson T R, Kulin N A, Tingey D, Iskedjian M Authors' objectives To indirectly quantify and compare the intraocular pressure (IOP)- lowering effects (...) of latanoprost and brimonidine eye drops at baseline and after 3 and 6 months in the treatment of primary open-angle glaucoma. Searching The authors searched MEDLINE and EMBASE (1992 to May 1999) using the search terms 'ophthalmic', 'glaucoma', 'clinical trial', and either 'latanoprost' or 'brimonidine'. References from the retrieved articles were searched for additional studies. The search was restricted to English language publications. Study selection Study designs of evaluations included in the review

DARE.2000